Peking University

This study tests a drug called AK104 in people with a specific type of stomach or colorectal cancer (MSI-H/dMMR). The drug is given before and after surgery to see if it can completely eliminate the tumor. About 47 participants will receive the treatment, and the main goal is to …

This study tests whether adding two targeted drugs (nimotuzumab and camrelizumab) to standard chemotherapy before surgery can improve outcomes for people with locally advanced esophageal cancer. About 48 adults aged 18-70 with resectable tumors will be randomly assigned to receiv…

This study tests a new treatment for people with advanced colorectal cancer that has spread to the liver and no longer responds to standard therapies. The approach combines a liver-directed chemotherapy infusion (HAIC), an immunotherapy drug (tislelizumab), and targeted drugs cho…

This study looks at 100 women with early-stage HR+/HER2- breast cancer to see if adding CDK4/6 inhibitors to standard hormone therapy before surgery improves outcomes. Researchers use a genetic risk score and early changes in a cell growth marker (Ki-67) to decide who gets the ex…

This study tests a program that uses digital health technology and personalized behavior coaching through WeChat to prevent obesity in school-aged children. About 1,400 children in grades 2 and 3 will take part, with some receiving the program and others getting usual care. Resea…

This study tests a new program to prevent obesity in preschool children (ages 4-6) in China. It uses digital health tools and teamwork between schools and health services to promote healthy habits. About 980 children from kindergartens will take part, and researchers will measure…

This study tests a mobile app that uses cognitive behavioral therapy (CBT) to help treat depression. About 146 adults aged 18-45 with moderate to severe depression will use the app for 8 weeks, guided by AI. The goal is to see if the app reduces depression symptoms and to explore…

This study looks at whether a personalized brain-training program can help older adults (60+) with high blood pressure who are at risk for memory loss. About 120 people will be split into two groups: one gets the real brain training, the other gets a placebo version. The training…

This study tests whether talking with AI chatbots can help adults better understand anxiety, reduce stigma, and feel more confident seeking help. About 200 participants will use either an AI chatbot, a chatbot with simulated anxiety conversations, or standard written materials fo…

This study looks at how people feel about using large language models (a type of AI) in medicine. Researchers will survey 3000 adults to see if providing information can change their acceptance of AI in healthcare. The goal is to understand public perceptions, not to test a treat…